This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

About UsMissionHistory & MilestonesManagement TeamSupervisory BoardComplianceOur Values

ITM – Steffen Schuster

Chief Executive Officer ITM Group

Steffen Schuster, Dipl.-Kfm. has been Chief Executive Officer of ITM since December 2011. During his time with ITM, Steffen has greatly expanded the development and production of medical radioisotopes and radiopharmaceuticals internationally and successfully led ITM from a pure radioisotope manufacturer to a global biotechnology and radiopharmaceutical company. In addition, he has concluded important strategic partnerships, secured relevant equity and debt financing, including a loan from the European Investment Bank, and opened new sites in Germany and USA as part of ITM’s growth course.

Prior to his work at ITM, Steffen was a General Partner at TVM Capital. Before that, he served as the Chief Financial Officer of the publicly listed cycos AG. Earlier in his career, Steffen worked for the Siemens Network Division where he held a variety of leading roles including international M&A as well as Co-founder of the Mustang Ventures fund with headquarters in Silicon Valley where he acted as Managing Director and Investment Partner.

Steffen received a Master’s Degree in Economics (Dipl.-Kfm.) from the University of Saarbrücken (Germany).